# LeMaitre to Participate at Upcoming Investor Conferences in June
Canonical URL: https://biopharmsignal.com/news/LMAT/lemaitre-to-participate-at-upcoming-investor-conferences-in-june-a4d71e69
Ticker: LMAT
Company: LeMaitre Vascular
Source: LeMaitre Vascular
Published: 2026-05-20 20:25 EST
## Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two...

## Article Body
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.

Jefferies Global Healthcare Conference Wednesday, June 3, 2026 Marriott Marquis, New York City Management will participate in a fireside chat at 10:30 AM EDT

Goldman Sachs Annual Global Healthcare Conference Wednesday, June 10, 2026 Loews Miami Beach Hotel, Miami Beach Management will present at 9:20 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com .

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.
## Recent Company News
- 2026-07-14 21:43 EST — [LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026-269755ae) — Source: LeMaitre Vascular
- 2026-05-20 20:25 EST — [LeMaitre to Participate at Upcoming Investor Conferences in June](https://biopharmsignal.com/news/LMAT/lemaitre-to-participate-at-upcoming-investor-conferences-in-june-a4d71e69) — Source: LeMaitre Vascular
- 2026-05-07 21:15 EST — [LeMaitre to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/LMAT/lemaitre-to-present-at-the-bank-of-america-healthcare-conference-3f9a75f1) — Source: LeMaitre Vascular
- 2026-05-05 20:05 EST — [LeMaitre Q1 2026 Financial Results](https://biopharmsignal.com/news/LMAT/lemaitre-q1-2026-financial-results-1a3119ae) — Source: LeMaitre Vascular
- 2026-04-14 20:54 EST — [LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026-b7240d53) — Source: LeMaitre Vascular
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)